university

Fear These Three Biotech Stocks: AVEO Pharmaceuticals, Inc …

They say good things come in threes. If so, biotech companies could be in for not just another year of outperformance, but another decade. The first era of biotech was a building phase, when companies created their first blockbuster drugs. The second, current one, has resulted in a four-year rally that reflects the sector’s transition from a cluster of one-hit […]

Biotech Stocks with Pessimistic Trend: Halozyme Therapeutics, Inc …

If there is such a thing as a poster child for volatility in the stock market, the biotech sector would likely take top honors.Biotech stocks are unique. While stocks in other sectors are typically valued based on their past performance and future earnings potential, the majority of biotech stocks don’t have a cent in recurring revenue. Instead, biotech stocks are […]

3 Biotech Stocks Are Getting Crushed: Achillion Pharmaceuticals …

Many individual investors have opted to invest in biotech ETFs and mutual funds. The XBI and SBIO funds have performed well because they focus more on small and mid-sized biotech companies. The IBB, which has emerged as something of a proxy for the industry for many investors, is weighted much more heavily to bigger, more proven biotech companies.The volatility of […]

Biotech Stocks: Here's Where to Get In: Omeros Corporation …

The S&P 500 Biotech Index has nearly tripled in the past three years. The index had stalled and moved sideways for much of the past spring, leading some to wonder whether the rally was spent. Several factors have been fueling the biotech rally of the past three years. For one thing, the U.S. Food and Drug Administration has been pushing […]

Overcoming ethnic divides key to fueling stock market growth in …

On the heels of President Barack Obama’s trip to Kenya this summer, in which the U.S. president called on Kenya to overcome ethnic divisions, a new study provides insights into the economic cost of segregation in developing countries and how to overcome it.

The study, published in Administrative Science Quarterly, looks at how actors from diverse and competing social groups can […]

Expert Sees Repeat of Horrors He Predicted: "Next Great Stock …

This article was written by Michael Snyder and originally published at his Economic Collapse blog.Editor’s Comment: The alarm bells of a looming crash have again and again sounded, with a constant stream of reports that show Americans at large have been screwed over again and again, while the same maniacal banksters who took us over the cliff last time up […]

An Expert That Correctly Called The Last Two Stock Market Crashes …

An Expert That Correctly Called The Last Two Stock Market Crashes Is Now Predicting Another One
By Michael Snyder, on July 28th, 2015What I am about to share with you is quite stunning.  A well-respected financial expert that correctly predicted the last two stock market crashes is now warning that we are right on the verge of the next one.  […]

Playmate Kennedy Summers day trading – Business Insider

Getty Images/ Mike WindleKennedy Summers, Playboy’s 2014 ‘Playmate of the Year.’See AlsoThe SEC is hunting hackers who stole corporate emails to trade stocksORDERED CHAOS: An annotated guide to the bustling trading floor of the Chicago Mercantile ExchangeJimmy Lee was the greatest investment banker of our time, but that’s not what made him specialPlayboy’s 2014 “Playmate of the Year,” Kennedy Summers, […]

Nuclear Stock Market – All Things Nuclear

Fission Stories #191News such as last year’s closure of four nuclear power reactors, this year’s closure of another reactor, and Exelon’s claim that many of its reactors cannot break even absent even greater subsidies suggests that now might not be the best time to invest in nuclear technology. But it doesn’t mean that nuclear technology need not be considered when […]

These Promising Cancer Therapies Are a Biotech Stocks "Triple Play"

These Promising Cancer Therapies Are a Biotech Stocks “Triple Play”Companies / BioTechJun 19, 2015 – 03:04 PM GMTBy: Money_MorningErnie Tremblay writes: On Jan. 7, 2015, CytRX Corp. (NASDAQ: CYTR) announced positive results from a study of its experimental brain cancer drug, aldoxorubicin, and the company’s stock immediately jumped 15.8%. Then, over the next four months, it nearly doubled.Over the months […]